Completed PHASE1/PHASE2 INTERVENTIONAL NCT00046722

Marijuana for HIV-Related Peripheral Neuropathy

Effects of Marijuana on Neuropathic Pain in HIV-Related Peripheral Neuropathy: A Randomized, Double-Blind, Placebo-Controlled Study.

Sponsor: Center for Medicinal Cannabis Research

Conditions HIV Infections Peripheral Nervous System Diseases

Interventions Smoked Marijuana

Updated 5 times since 2017 Last updated: Jun 12, 2007 Started: Jan 31, 2003 Completion: Apr 30, 2005

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE1/PHASE2 trial investigates HIV Infections and Peripheral Nervous System Diseases and is currently completed. Center for Medicinal Cannabis Research leads this study, which shows 5 recorded versions since 2003 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1/PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1/PHASE2

Phase: PHASE1_PHASE2 → PHASE1/PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE1_PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE1_PHASE2
Jan 2017 — Jun 2018 [monthly]

Completed PHASE1_PHASE2

First recorded

Jan 2003

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Center for Medicinal Cannabis Research

Data source: Center for Medicinal Cannabis Research

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• San Francisco, United States